Peripheral immuno-inflammatory abnormalities in ultra-high risk of developing psychosis

Schizophr Res. 2016 Oct;176(2-3):191-195. doi: 10.1016/j.schres.2016.06.031. Epub 2016 Aug 8.

Abstract

Background: Immuno-inflammatory imbalances have been documented in schizophrenia, but very little is known about the immunological changes prior to the onset of disease.

Objective: This work aimed to compare serum levels of pro- and anti-inflammatory cytokines in young subjects at ultra-high risk (UHR) of developing psychosis with age- and sex-matched healthy controls.

Methods: A total of 12 UHR and 16 age- and sex-matched healthy controls (HC) subjects were enrolled in this study. Clinical profile was assessed using the Comprehensive Assessment of At-Risk Mental States (CAARMS), Semi-Structured Clinical Interview for DSM-IV Axis-I (SCID-I) or Kiddie-SADS-Present and Lifetime Version (K-SADS-PL), and Global Assessment of Functioning (GAF) scale. Serum interleukin (IL)-2, IL-4, IL-6, IL-10, tumor necrosis factor (TNF)-α, IFN-γ, and IL-17 were measured by flow cytometry using the Th1/Th2/Th17 cytometric bead array.

Results: Compared with the healthy control group, patients in UHR showed increased IL-6 levels (Z=-2.370, p=0.018) and decreased IL-17 levels in serum (Z=-1.959, p=0.050). Levels of IL-17 positively correlated to the values in GAF symptoms (rho=0.632, p=0.028).

Conclusion: Our results suggest that immunological imbalances could be present in the early stages of psychosis, including in at-risk stages. Future studies should replicate and expand these results.

Keywords: Cytokines; Inflammation; Prodromal; Psychosis; Schizophrenia; Ultra-high risk.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Antipsychotic Agents / therapeutic use
  • Biomarkers / blood
  • Cross-Sectional Studies
  • Cytokines / blood*
  • Female
  • Humans
  • Interview, Psychological
  • Male
  • Psychiatric Status Rating Scales
  • Psychotic Disorders / blood*
  • Psychotic Disorders / drug therapy
  • Psychotic Disorders / immunology*
  • Risk
  • Young Adult

Substances

  • Antipsychotic Agents
  • Biomarkers
  • Cytokines